Jill Marie Broadfoot - 20 Nov 2021 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
20 Nov 2021
Net transactions value
$0
Form type
4
Filing time
23 Nov 2021, 16:37:13 UTC
Previous filing
20 Aug 2021
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Award $0 +15,000 $0.000000 15,000 20 Nov 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACRX Stock Option (Right to Receive) Award $0 +30,000 $0.000000 30,000 20 Nov 2021 Common Stock 30,000 $0.7200 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units shall vest in three equal consecutive annual installments on November 20, 2022, November 20, 2023 and November 20, 2024.
F3 The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months.